Liu Q - Search Results

1

Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis.

Zhong G, Wei W, Liao W, Wang R, Peng Y, Zhou Y, Huang X, Xian S, Peng S, Zhang Z, Feng S, Liu Y, Hong H, Xia Y, Yan Y, Liu Q, Liu Z. Zhong G, et al. Among authors: liu z, liu y, liu q. Front Oncol. 2022 May 23;12:859721. doi: 10.3389/fonc.2022.859721. eCollection 2022. Front Oncol. 2022. PMID: 35677160 Free PMC article.

2

Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads.

Tao YL, Li Y, Gao J, Liu ZG, Tu ZW, Li G, Xu BQ, Niu DL, Jiang CB, Yi W, Li ZQ, Li J, Wang YM, Cheng ZB, Liu QD, Bai L, Zhang C, Zhang JY, Zeng MS, Xia YF. Tao YL, et al. J Cell Biochem. 2012 Jul;113(7):2268-78. doi: 10.1002/jcb.24097. J Cell Biochem. 2012. PMID: 22334501

3

Treatment of Locally Advanced Nasopharyngeal Carcinoma by Helical Tomotherapy: An Observational, Prospective Analysis.

Liu Z, Xu C, Jiang R, Liu G, Liu Q, Zhou J, Liu F, Yao J, Wang S, Jiang W. Liu Z, et al. Among authors: liu q, liu g, liu f. Transl Oncol. 2019 May;12(5):757-763. doi: 10.1016/j.tranon.2019.02.011. Epub 2019 Mar 15. Transl Oncol. 2019. PMID: 30878894 Free PMC article.

4

Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?

Yao JJ, Jin YN, Liu ZG, Liu QD, Pei XF, Zhou HL, Zhang WJ, Zhang F, Lin L, Lawrence WR, Wang SY, Ma J, Zhou GQ, Sun Y. Yao JJ, et al. Ther Adv Med Oncol. 2019 Mar 21;11:1758835919833863. doi: 10.1177/1758835919833863. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 30923578 Free PMC article.

5

Postoperative intensity-modulated radiation therapy reduces local recurrence and improves overall survival in III-N2 non-small-cell lung cancer: A single-center, retrospective study.

Wei W, Zhou J, Zhang Q, Liao DH, Liu QD, Zhong BL, Liang ZB, Zhang YC, Jiang R, Liu GY, Xu CY, Li Zhou H, Zhu SY, Yang N, Jiang W, Liu ZG. Wei W, et al. Among authors: liu gy, liu qd, liu zg. Cancer Med. 2020 Apr;9(8):2820-2832. doi: 10.1002/cam4.2937. Epub 2020 Feb 26. Cancer Med. 2020. PMID: 32100444 Free PMC article. Clinical Trial.

6

Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe.

Deng Z, Liao W, Wei W, Zhong G, He C, Zhang H, Liu Q, Xu X, Liang J, Liu Z. Deng Z, et al. Among authors: liu z, liu q. Cancer Cell Int. 2021 Jan 9;21(1):37. doi: 10.1186/s12935-020-01721-x. Cancer Cell Int. 2021. PMID: 33422069 Free PMC article.

7

Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.

Peng YP, Liu QD, Lin YJ, Peng SL, Wang R, Xu XW, Wei W, Zhong GH, Zhou YL, Zhang YQ, Liu Y, Wang SY, Hong HY, Liu ZG. Peng YP, et al. Radiat Oncol. 2021 Oct 11;16(1):198. doi: 10.1186/s13014-021-01898-z. Radiat Oncol. 2021. PMID: 34635145 Free PMC article.

8

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.

Peng YP, Wang R, Liu QD, Xu XW, Wei W, Huang XT, Peng XM, Liu ZG. Peng YP, et al. Front Genet. 2021 Nov 16;12:756506. doi: 10.3389/fgene.2021.756506. eCollection 2021. Front Genet. 2021. PMID: 34868231 Free PMC article.

9

Clinical Characteristics and Prognosis of Small Cell Carcinoma in the Nasopharynx: A Population-Based Study.

Zhou YL, Peng YP, Liu QD, Chen XZ, He J, Wei W, Zhong GH, Zhang YQ, Liu Y, Pan JY, Feng SY, Liu ZG. Zhou YL, et al. Cancer Control. 2022 Jan-Dec;29:10732748221087075. doi: 10.1177/10732748221087075. Cancer Control. 2022. PMID: 35341342 Free PMC article.

10

Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.

Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, Jin F, Shi M, Chen YP, Hu WH, Cheng ZB, Wang SY, Tian Y, Wang XC, Sun Y, Li JG, Li WF, Li YH, Mao YP, Zhou GQ, Sun R, Liu X, Guo R, Long GX, Liang SQ, Li L, Huang J, Long JH, Zang J, Liu QD, Zou L, Su QF, Zheng BM, Xiao Y, Guo Y, Han F, Mo HY, Lv JW, Du XJ, Xu C, Liu N, Li YQ, Xie FY, Sun Y, Ma J, Tang LL. Zhang Y, et al. J Clin Oncol. 2022 Aug 1;40(22):2420-2425. doi: 10.1200/JCO.22.00327. Epub 2022 Jun 16. J Clin Oncol. 2022. PMID: 35709465 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42,580 results

Search Page